This book collects salient observational data, derived predominantly from human studies, regarding the mechanism(s) of rejection in various pathologic conditions; the premise is that immune rejection, better defined as “immune-mediated, tissue-specific destruction” (TSD), comprises a broad range of phenomena ranging from tumor regression, to clearance of pathogen through destruction of infected cells, autoimmunity, allograft rejection by the host and host versus graft reactions. Like different hands can turn on or off a switch, distinct mechanisms can trigger TSD; however, a convergent pathway is ultimately observed when TSD occurs consisting of a dramatic switch from chronic to acute inflammation leading to the activation of a restricted number of genes that we comprise in the immunologic constant of rejection (ICR) model. Although the ICR model does not address “why” rejection occurs but rather “how”, and it may not contribute an explanation for the determinism of rejection, it provides, if correct, a simplified road map about the convergent pathways leading to TSD. This offers the opportunity to identify a common target for immune manipulation with therapeutic purposes since ICR-related pathways are restricted in expression to the tissues in which TSD occurs while are shut off in the rest of a normal organism. The book includes chapters from outstanding basic and/or observational scientists that have contributed to this area either by defining mechanisms relevant to the understanding of the inflammatory switch or by describing how this occurs in human tissues under different pathological conditions. We would like to entice our reader(s) to test with us, through, the readings, whether our hypothesis is correct; we predict that common themes will emerge particularly if attention will be paid to the general phenomenon of TSD rather than the peculiarities of individual pathologies. With the hope of having contributed with this book something novel and important and we wish our reader a pleasant journey in the wondrous land of immune-mediated, tissue-specific destruction.
Author(s): Ena Wang, Francesco M. Marincola (auth.), Francesco M. Marincola, Ena Wang (eds.)
Edition: 1
Publisher: Springer-Verlag New York
Year: 2011
Language: English
Pages: 353
Tags: Cancer Research
Front Matter....Pages i-vii
Front Matter....Pages 1-1
From the “Delayed Allergy Reaction” to the “Immunologic Constant of Rejection”....Pages 3-8
Front Matter....Pages 9-9
The Yin Yang of Cancer Related Inflammation....Pages 11-16
The Immune Rejection: Lessons from Experimental Models....Pages 17-25
Turning on and off the Immunological Switch: Immune Response Polarization and Its Control by IL-10 and STAT3....Pages 27-55
The Angiogenic Switch: Role of Immune Cells....Pages 57-75
Chemokines and Cytotoxic Effector Molecules in Rejection....Pages 77-92
Clinical Applications of Activated Immune Cells....Pages 93-102
Front Matter....Pages 103-103
Blood Transcriptional Fingerprints to Assess the Immune Status of Human Subjects....Pages 105-125
Innate Signatures of Immune Mediated Resolution and Persistence of Hepatitis C Virus Infections....Pages 127-140
Immune Signatures and Systems Biology of Vaccines....Pages 141-167
Immune Signatures Associated with the Cancer Bearing State....Pages 169-186
Front Matter....Pages 187-187
HTLV-1 Infected CD4 + CD25 + CCR4 + T-Cells Disregulate Balance of Inflammation and Tolerance in HTLV-1 Associated Neuroinflammatory Disease....Pages 189-198
D/2 Predictors of Favorable Outcome in Cancer....Pages 199-210
The Microenvironment of Ovarian Cancer: Lessons on Immune Mediated Tumor Rejection or Tolerance....Pages 211-228
Transcriptional Profiling of Melanoma as a Potential Predictive Biomarker for Response to Immunotherapy....Pages 229-238
Functional Pathway Analysis for Understanding Immunologic Signature of Rejection: Current Approaches and Outstanding Challenges....Pages 239-256
Front Matter....Pages 257-257
Chronic Graft Versus Host Disease: Inflammation at the Crossroads of Allo and Auto Immunity....Pages 259-280
Immune-Mediated Tumor Rejection....Pages 281-304
Signatures Associated with Acute Rejection: Allograft Rejection....Pages 305-345
Back Matter....Pages 347-353